Beckman Coulter Diagnostics receives CE-Mark under IVDR for its Access p-Tau217 assay: Brea, California Wednesday, July 8, 2026, 11:00 Hrs [IST] Beckman Coulter Diagnostics, a glo ...

Immunocine Cancer Center today announced the appointment of Vita S. Salsman as Executive Director. Salsman brings more than two decades of experience in cancer immunotherapy, cell therapy ...

The Association for Diagnostics & Laboratory Medicine (ADLM) is pleased to announce that H. Timothy Hsiao, PhD, CSAP, has been named chief scientific officer for the organization, effective July 21.

Years ago, LSD was seen as the evil stepchild of drugs. Today, research indicates LSD may treat anxiety and depression, and ...

Cancer Center has opened the Hoʻōla Early Phase Clinical Research Center, a new Kakaʻako facility intended to expand local ...

UCSF researchers are using tiny "mini-organs" to model disease, personalize treatment, and understand human development. They ...

Biomedical engineer Sangeeta Bhatia reflects on her journey in pioneering liver research, developing advanced diagnostics, ...

As instruments grow faster, leaders say clinical impact will depend on trust, standards, data, and assays built for real ...

Large language models (LLMs) are rapidly being integrated into clinical workflows, supporting tasks such as diagnosis ...

Starting today, Dr. David Gius is officially in the driver’s seat at the University of Cincinnati Cancer Center after a national search that drew leaders from top research programs across the country.

A new form of CAR T-cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...